These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 7219060)

  • 21. Enkephalin analogues and naloxone modulate the release of growth hormone and prolactin--evidence for regulation by an endogenous opioid peptide in brain.
    Shaar CJ; Frederickson RC; Dininger NB; Jackson L
    Life Sci; 1977 Sep; 21(6):853-60. PubMed ID: 916803
    [No Abstract]   [Full Text] [Related]  

  • 22. Evidence that chronic hyperprolactinemia effects skin temperature regulation through an opioid mechanism.
    Simpkins JW; Taylor ST; Gabriel SM; Katovich MJ; Millard WJ
    Neuroendocrinology; 1984 Oct; 39(4):321-9. PubMed ID: 6092986
    [TBL] [Abstract][Full Text] [Related]  

  • 23. FSH-induced Sertoli cell proliferation in the developing rat is modified by beta-endorphin produced in the testis.
    Orth JM
    Endocrinology; 1986 Oct; 119(4):1876-8. PubMed ID: 2944740
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Changes in social behaviour of rats following chronic treatment with gamma-endorphin antiserum injected into the nucleus accumbens.
    Niesink RJ; Van Ree JM
    Neuropharmacology; 1983 Jul; 22(7):819-26. PubMed ID: 6194469
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Endogenous opioid peptides and hypothalamo-pituitary function.
    Howlett TA; Rees LH
    Annu Rev Physiol; 1986; 48():527-36. PubMed ID: 3010826
    [No Abstract]   [Full Text] [Related]  

  • 26. Endogenous opioid peptides and blood pressure regulation during controlled, stepwise hemorrhagic hypotension.
    van den Berg MH; van Giersbergen PL; Cox-van Put J; de Jong W
    Circ Shock; 1991 Oct; 35(2):102-8. PubMed ID: 1723353
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Does beta-endorphin modulate basal and dopamine-inhibited prolactin release by an action at the anterior pituitary?
    Cheung CY
    Neuroendocrinology; 1984 Dec; 39(6):489-95. PubMed ID: 6096753
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Stimulation of prolactin secretion in the rat by alpha-neo-endorphin, beta-neo-endorphin and dynorphin.
    Matsushita N; Kato Y; Shimatsu A; Katakami H; Fujino M; Matsuo H; Imura H
    Biochem Biophys Res Commun; 1982 Jul; 107(2):735-41. PubMed ID: 6127078
    [No Abstract]   [Full Text] [Related]  

  • 29. Brain opioid peptides and the control of prolactin secretion: neonatal organization.
    Piva F; Limonta P; Martini L
    Monogr Neural Sci; 1983; 9():201-4. PubMed ID: 6888406
    [No Abstract]   [Full Text] [Related]  

  • 30. Evidence for endogenous opioid modulation of serum luteinizing hormone and prolactin in the steer.
    Peck DD; Thompson FN; Stuedemann JA; Leshin LS; Kiser TE
    J Anim Sci; 1988 Dec; 66(12):3197-201. PubMed ID: 3230079
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Naloxone and intestinal motility.
    Howd RA; Adamovics A; Palekar A
    Experientia; 1978 Oct; 34(10):1310-1. PubMed ID: 216571
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Naloxone fails to block ECT-induced prolactin increase.
    Papakostas YG; Stefanis CC; Markianos M; Papadimitriou GN
    Biol Psychiatry; 1985 Dec; 20(12):1326-7. PubMed ID: 4063423
    [No Abstract]   [Full Text] [Related]  

  • 33. Restraint stress decreases afternoon plasma prolactin levels in female rats. Influence of neural antagonists and agonists on restraint-induced changes in plasma prolactin and corticosterone.
    Gala RR; Haisenleder DJ
    Neuroendocrinology; 1986; 43(2):115-23. PubMed ID: 3724981
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Opioid effects on plasma concentrations of luteinizing hormone and prolactin in the adult male rhesus monkey.
    Gilbeau PM; Almirez RG; Holaday JW; Smith CG
    J Clin Endocrinol Metab; 1985 Feb; 60(2):299-305. PubMed ID: 2981242
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hyperprolactinemia decreases the luteinizing hormone-releasing hormone concentration in pituitary portal plasma: a possible role for beta-endorphin as a mediator.
    Sarkar DK; Yen SS
    Endocrinology; 1985 May; 116(5):2080-4. PubMed ID: 3157564
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Opioid modulation of thyrotropin releasing hormone induced prolactin secretion.
    Buydens P; Velkeniers B; Golstein J; Finné E; Vanhaelst L
    Life Sci; 1987 Mar; 40(12):1207-14. PubMed ID: 3104708
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of morphine and naloxone on serum levels of luteinizing hormone and prolactin in prepubertal male and female rats.
    Ieiri T; Chen HT; Meites J
    Neuroendocrinology; 1979; 29(4):288-92. PubMed ID: 514456
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Beta-endorphin and dynorphin control serum luteinizing hormone level in immature female rats.
    Schulz R; Wilhelm A; Pirke KM; Gramsch C; Herz A
    Nature; 1981 Dec; 294(5843):757-9. PubMed ID: 6119618
    [No Abstract]   [Full Text] [Related]  

  • 39. Suckling-induced prolactin release is suppressed by naloxone and simulated by beta-endorphin.
    Selmanoff M; Gregerson KA
    Neuroendocrinology; 1986; 42(3):255-9. PubMed ID: 2936973
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of naloxone on serum corticosterone and gastric lesions in stressed rats.
    Dai S; Chan MY
    Pharmacology; 1983; 27(3):180-4. PubMed ID: 6622518
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.